ArticleSurgical endoscopy2026
Balloon dilation versus endoscopic stricturotomy in the treatment of Crohn's anastomotic stricture: experimental randomized study.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundUp to 80% of patients with Crohn's disease (CD) require surgery, and anastomotic strictures are a frequent postoperative complication with limited response to medical therapy. Endoscopic balloon dilation (EBD) and endoscopic stricturotomy (ESt) are widely used minimally invasive treatments, though comparative evidence remains scarce. Standardized animal models enable controlled assessment of therapeutic efficacy. This study compared EBD and ESt in a randomized experimental model replicating CD-associated anastomotic strictures.
methodsA chemically induced anastomotic stricture model was established in miniature pigs using a standardized ileo-sigmoid side-to-side anastomosis followed by serial TNBS/phenol injections. Forty-four animals with confirmed strictures were randomized to EBD, ESt, or control groups. Interventions consisted of graded balloon dilation or needle-knife stricturotomy with clip closure. Stricture diameter was measured endoscopically at baseline and every 8 weeks for 6 months. Primary outcomes were change in anastomotic diameter and long-term luminal patency. Secondary outcomes included adverse events and animal welfare indicators.
resultsBoth EBD and ESt increased anastomotic diameter compared with baseline. Significant improvement occurred only after ESt (final diameter 17.51 ± 4.71 mm vs. 11.27 ± 1.46 mm at baseline; p = 0.0002). EBD produced a non-significant trend toward enlargement (16.09 ± 5.35 mm; p = 0.0554). Diameter gain over 6 months was significantly greater with ESt than EBD (6.24 ± 4.40 mm vs. 3.31 ± 5.01 mm; p = 0.042). Controls showed no meaningful change. Three perforations occurred (two EBD, one ESt), all treated endoscopically without mortality. Weight gain and overall health status were comparable across groups throughout follow-up.
conclusionIn this randomized experimental study, both EBD and ESt were technically feasible and safe. ESt resulted in significantly greater and more durable luminal enlargement than EBD. These findings support stricturotomy as a potentially more effective endoscopic option for fibrostenotic CD and may help reduce or delay surgical intervention in affected patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.